BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 15742639)

  • 1. Vaccination: foot-and-mouth disease experience in South America.
    Bergmann IE; Malirat V; Neitzert E; Correa Melo E
    Dev Biol (Basel); 2004; 119():273-82. PubMed ID: 15742639
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-capsid proteins to identify foot-and-mouth disease viral circulation in cattle irrespective of vaccination.
    Bergmann IE; Malirat V; Neitzert E
    Biologicals; 2005 Dec; 33(4):235-9. PubMed ID: 16257539
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evolving perception on the benefits of vaccination as a foot and mouth disease control policy: contributions of South America.
    Bergmann IE; Malirat V; Falczuk AJ
    Expert Rev Vaccines; 2005 Dec; 4(6):903-13. PubMed ID: 16372885
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vaccines and companion diagnostic tests for foot-and-mouth disease virus. An overview of the experience in South America.
    Bergmann IE; Malirat V; Neitzert E; Correa Melo E
    Dev Biol (Basel); 2003; 114():59-65. PubMed ID: 14677677
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of an inhibition ELISA test for the detection of non-capsid polyprotein 3ABC in viral suspensions destined for inactivated foot-and-mouth disease vaccines.
    Bergmann IE; Neitzert E; Malirat V; de Mendonça Campos R; Pulga M; Muratovik R; Quintino D; Morgados JC; Oliveira M; de Lucca Neto D
    Dev Biol (Basel); 2006; 126():241-50; discussion 327. PubMed ID: 17058500
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vaccines and foot-and-mouth disease eradication in South America.
    Saraiva V
    Dev Biol (Basel); 2003; 114():67-77. PubMed ID: 14677678
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The use of vaccines in South American foot-and-mouth disease eradication programmes.
    Saraiva V; Darsie G
    Dev Biol (Basel); 2004; 119():33-40. PubMed ID: 15742616
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Application of non-structural protein antibody tests in substantiating freedom from foot-and-mouth disease virus infection after emergency vaccination of cattle.
    Paton DJ; de Clercq K; Greiner M; Dekker A; Brocchi E; Bergmann I; Sammin DJ; Gubbins S; Parida S
    Vaccine; 2006 Oct; 24(42-43):6503-12. PubMed ID: 16872727
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development and characterization of a bovine serum evaluation panel as a standard for immunoassays based on detection of antibodies against foot-and-mouth disease viral non-capsid proteins.
    Campos Rde M; Malirat V; Neitzert E; Grazioli S; Brocchi E; Sanchez C; Falczuk AJ; Ortiz S; Rebello MA; Bergmann IE
    J Virol Methods; 2008 Jul; 151(1):15-23. PubMed ID: 18499275
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-structural protein 3A for differentiation of foot-and-mouth disease infected and vaccinated animals in Haryana (India).
    Kumar N; Sharma R; Kakker NK
    Zoonoses Public Health; 2007; 54(9-10):376-82. PubMed ID: 18035976
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Foot-and-mouth disease control using vaccination: South African experience.
    Brückner GK; Vosloo W; Cloete M; Dungu B; Du Plessis BJ
    Dev Biol (Basel); 2004; 119():51-62. PubMed ID: 15742618
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Foot-and-Mouth disease control using vaccination: the Dutch experience in 2001.
    Pluimers FH
    Dev Biol (Basel); 2004; 119():41-9. PubMed ID: 15742617
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of emergency FMD vaccine antigen payload on protection, sub-clinical infection and persistence following direct contact challenge of cattle.
    Cox SJ; Voyce C; Parida S; Reid SM; Hamblin PA; Hutchings G; Paton DJ; Barnett PV
    Vaccine; 2006 Apr; 24(16):3184-90. PubMed ID: 16488060
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of foot-and-mouth disease virus infection in vaccinated cattle.
    Niedbalski W
    Pol J Vet Sci; 2005; 8(4):283-7. PubMed ID: 16385852
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Foot-and-Mouth disease 'vaccination-to-live': possibilities and constraints.
    Roth JA
    Dev Biol (Basel); 2004; 119():267-72. PubMed ID: 15742638
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of protective immunity in swine by immunization with live attenuated recombinant pseudorabies virus expressing the capsid precursor encoding regions of foot-and-mouth disease virus.
    Li X; Liu R; Tang H; Jin M; Chen H; Qian P
    Vaccine; 2008 May; 26(22):2714-22. PubMed ID: 18436351
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The role of reference laboratories in animal health programmes in South America].
    Bergmann IE
    Rev Sci Tech; 2003 Aug; 22(2):537-45. PubMed ID: 15884590
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vaccination against foot and mouth disease reduces virus transmission in groups of calves.
    Orsel K; Dekker A; Bouma A; Stegeman JA; de Jong MC
    Vaccine; 2005 Sep; 23(41):4887-94. PubMed ID: 16002192
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The NSP immune response of vaccinated animals after in-field exposure to FMDV.
    Yadin H; Brenner J; Chai D; Oved Z; Hadany Y; Kusak A; Haimovich M
    Vaccine; 2007 Nov; 25(49):8298-305. PubMed ID: 17981376
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Seroepidemiologic indicators for the evaluation of campaigns for the control of foot-and-mouth disease].
    Fondevila N; O'Donnell V; Duffy S; León E; Smitsaart E; Schudel AA
    Rev Sci Tech; 1997 Dec; 16(3):784-92. PubMed ID: 9567304
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.